SMTL ID : 2ym5.1

Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

monomer

Ligands

1 x YM5: (3-{4-[(2S)-2-(AMINOMETHYL)MORPHOLIN-4-YL]-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL}PHENYL)METHANOL(Non-covalent)

YM5.1: 14 residues within 4Å: Chain A: L.15, G.16, V.23, A.36, L.84, E.85, Y.86, C.87, E.91, E.134, N.135, L.137, S.147, D.148 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.23, A:L.84, A:L.137 Hydrogen bonds: A:E.85, A:C.87, A:E.134, A:S.147 Water bridges: A:N.135

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 3 residues within 4Å: Chain A: W.221, H.243, L.246 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.243, A:H.243

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Reader, J.C. et al., Structure-Guided Evolution of Potent and Selective Chk1 Inhibitors Through Scaffold Morphing. J.Med.Chem. (2011)

Release Date

2012-01-11

Peptides

SERINE/THREONINE-PROTEIN KINASE CHK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

SERINE/THREONINE-PROTEIN KINASE CHK1

Related Entries With Identical Sequence